Companies › VNRX
VolitionRx Limited (VNRX)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0000093314 · EDGAR filings · Updated 2026-07-21
VolitionRx Limited (VNRX) has reported institutional ownership of 14.1%, with 31 institutional managers holding positions valued at $4.52M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-21 — Current report (8-K) filed
- 2026-07-17 — EFFECT filed
- 2026-07-10 — Shelf registration (S-3) filed
- 2026-06-18 — Current report (8-K) filed
- 2026-06-10 — Current report (8-K) filed
- 2026-06-09 — Prospectus supplement (424B5) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, VolitionRx Limited has 31 institutional holders and institutional ownership of 14.1%.
Insider activity
Insiders reported 112 transactions (11 buys, 0 sells) across 18 reporting insiders, with a net reported value of $295.0K.
Data flags from SEC filings
Related companies
XBiotech Inc (XBIT) · HYPERION DEFI INC (HYPD) · Senti Biosciences Inc (SNTI) · RAFAEL HLDGS INC COM CL B (RFL) · YD BIO LTD (YDES) · DYADIC INTL INC DEL (DYAI)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-21.